Nova Leap Health Corp.
TSXV:NLH.V
0.29 (CAD) • At close March 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 25.761 | 26.179 | 28.205 | 21.279 | 17.309 | 17.405 | 10.362 | 1.06 | 0.04 |
| Cost of Revenue
| 15.874 | 16.411 | 18.23 | 14.068 | 11.438 | 11.56 | 7.042 | 0.694 | 0.025 |
| Gross Profit
| 9.887 | 9.768 | 9.975 | 7.211 | 5.871 | 5.845 | 3.32 | 0.366 | 0.015 |
| Gross Profit Ratio
| 0.384 | 0.373 | 0.354 | 0.339 | 0.339 | 0.336 | 0.32 | 0.345 | 0.386 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 8.44 | 8.423 | 9.682 | 7.581 | 5.723 | 5.339 | 3.641 | 1.177 | 0.44 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.013 | 0.002 |
| SG&A
| 8.44 | 8.423 | 9.682 | 7.581 | 5.723 | 5.339 | 3.641 | 1.19 | 0.442 |
| Other Expenses
| 0.584 | 0.885 | 1.356 | -4.264 | -1.667 | 0.619 | 0.443 | 0.036 | 0.039 |
| Operating Expenses
| 9.023 | 9.308 | 11.038 | 3.317 | 4.057 | 5.958 | 4.084 | 1.225 | 0.481 |
| Operating Income
| 0.864 | 0.46 | -1.1 | 3.894 | 1.815 | -0.113 | 0.764 | -0.907 | -0.515 |
| Operating Income Ratio
| 0.034 | 0.018 | -0.039 | 0.183 | 0.105 | -0.006 | 0.074 | -0.856 | -12.884 |
| Total Other Income Expenses Net
| 0.948 | -1.826 | -0.144 | 3.705 | 0.522 | -0.838 | -0.277 | -0.019 | -0.042 |
| Income Before Tax
| 1.812 | -1.366 | -1.207 | 2.473 | 0.126 | -0.951 | -1.041 | -0.926 | -0.518 |
| Income Before Tax Ratio
| 0.07 | -0.052 | -0.043 | 0.116 | 0.007 | -0.055 | -0.1 | -0.874 | -12.942 |
| Income Tax Expense
| 0.434 | -0.311 | -0.371 | 0.713 | -1.131 | 0.105 | -0.079 | -0.074 | -0.028 |
| Net Income
| 1.378 | -1.055 | -0.836 | 1.761 | 1.256 | -1.056 | -0.961 | -0.852 | -0.49 |
| Net Income Ratio
| 0.054 | -0.04 | -0.03 | 0.083 | 0.073 | -0.061 | -0.093 | -0.804 | -12.241 |
| EPS
| 0.016 | -0.012 | -0.011 | 0.02 | 0.02 | -0.017 | -0.02 | -0.041 | -0.044 |
| EPS Diluted
| 0.016 | -0.012 | -0.011 | 0.02 | 0.02 | -0.017 | -0.02 | -0.041 | -0.044 |
| EBITDA
| 2.503 | 0.994 | 0.42 | 4.755 | 2.359 | 0.128 | -0.285 | -0.868 | -0.462 |
| EBITDA Ratio
| 0.097 | 0.038 | 0.015 | 0.223 | 0.136 | 0.007 | -0.027 | -0.819 | -11.544 |